Adial Pharmaceuticals Inc (ADIL)
1.70
-0.09
(-5.03%)
USD |
NASDAQ |
May 03, 16:00
1.70
0.00 (0.00%)
After-Hours: 20:00
Adial Pharmaceuticals Free Cash Flow: -6.807M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
December 31, 2023 | -6.807M |
September 30, 2023 | -7.335M |
June 30, 2023 | -9.348M |
March 31, 2023 | -10.99M |
December 31, 2022 | -11.19M |
September 30, 2022 | -11.81M |
June 30, 2022 | -11.93M |
March 31, 2022 | -11.60M |
December 31, 2021 | -12.01M |
September 30, 2021 | -12.19M |
June 30, 2021 | -10.87M |
March 31, 2021 | -8.651M |
December 31, 2020 | -7.633M |
Date | Value |
---|---|
September 30, 2020 | -6.772M |
June 30, 2020 | -6.288M |
March 31, 2020 | -6.443M |
December 31, 2019 | -6.339M |
September 30, 2019 | -5.690M |
June 30, 2019 | -4.956M |
March 31, 2019 | -4.005M |
December 31, 2018 | -2.498M |
September 30, 2018 | -1.517M |
June 30, 2018 | -0.6621M |
March 31, 2018 | -0.6238M |
December 31, 2017 | -0.4949M |
Free Cash Flow Range, Past 5 Years
-12.19M
Minimum
Sep 2021
-4.956M
Maximum
Jun 2019
-8.887M
Average
-8.651M
Median
Mar 2021
Free Cash Flow Benchmarks
BioVie Inc | -41.11M |
BioSig Technologies Inc | -17.50M |
Precision BioSciences Inc | -86.39M |
Humacyte Inc | -75.58M |
Monogram Orthopaedics Inc | -13.61M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -1.223M |
Cash from Investing (Quarterly) | 0.35M |
Cash from Financing (Quarterly) | 3.384M |
Free Cash Flow Per Share (Quarterly) | -0.735 |
Free Cash Flow Yield | -318.3% |